RE:Save poor Bioniche.com
Keep your eye on No. 6 wussy.
Something very fishy indeed and me thinks this has everything to do with Urocidin and the MCC platform being sold. Could a partner or buyer for Urocidin and the MCC platform be waiting in the wings?
From the G-W press release, it says …
Econiche and Urocidin will be partnered or sold to produce the maximum return possible but will no longer be a focus of the company (and no longer a drain on the cash resources of the company).
Bioniche has spent well over $100 million on research, development, patenting and Phase I, II and III trials. And after all that, Urocidin, has proved to be total success in terms of safety and efficiency.
Does it make any sense to sell it off at this time when we’re so close to the finish line? No, I didn’t think so either.
Neither product fits Bioniche from a financial or risk perspective.
Total B-S!
The risk of getting these products approved and to market is high, the cost is prohibitive for Bioniche, and the timeline to revenue is highly uncertain.
On the eve of obtaining access to the Canadian market?
Bioniche will become a great Canadian life sciences company focused on animal health.
In your dreams!
No, the big money is in human health … so let’s sell the animal health division to the highest bidder and …
The Bioniche shareholders will own a great rich Canadian life sciences company focused on human health.
Until, buy, hold and accumulate.